Abstract
Rationale
The drug ±3,4-methylenedioxymethamphetamine (MDMA, “ecstasy,” “molly”) is thought to produce prosocial effects and enhance social interaction. However, in most laboratory studies to date, the participants have been tested under nonsocial conditions, which may not simulate the effects the drug produces in more naturalistic social settings.
Methods
Healthy experienced MDMA users participated in three laboratory sessions in which they received MDMA (0.5 or 1.0 mg/kg or placebo, double blind). They were randomly assigned to one of three social conditions, in which they were tested alone (solitary (SOL); N = 10), in the presence of a research assistant (research assistant present (RAP); N = 11) or in the presence of another participant who also received the drug (other participant present (OPP); N = 11).
Results
As expected, MDMA increased heart rate and blood pressure and produced positive subjective effects in all the three groups. It also increased ratings of attractiveness of another person and increased social interaction in RAP and OPP. The social context affected certain responses to the drug. The effects of MDMA were greater in the OPP condition, compared to the SOL or RAP conditions, on measures of “feel drug,” “dizzy,” and on cardiovascular. But responses to the drug on other measures, including social behavior, did not differ across the conditions.
Conclusions
These findings provide some support for the idea that drugs produce greater effects when they are used in the presence of other drug users. However, the influence of the social context was modest, and it remains to be determined whether other variables related to social context would substantially alter the effects of MDMA or other drugs.
Similar content being viewed by others
References
aan het Rot M, Moskowitz DS et al (2006) Social behaviour and mood in everyday life: the effects of tryptophan in quarrelsome individuals. J Psychiatry Neurosci 31:253–262
American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders, 4th edition, text revision. American Psychiatric Association, Washington
Bedi G, Phan KL, Angstadt M, de Wit H (2009) Effects of MDMA on sociability and neural response to social threat and social reward. Psychopharmacology (Berl) 207(1):73–83
Bedi G, Hyman D, de Wit H (2010) Is ecstasy an “empathogen”? Effects of +/−3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biol Psychiatry 68(12):1134–1140
Bos PA, Panksepp J, Bluthe RM, Honk JV (2011) Acute effects of steroid hormones and neuropeptides on human social-emotional behavior: a review of single administration studies. Front Neuroendocrinol
Bravo GL (2001) What does MDMA feel like? In: Holland J (ed) Ecstasy: the complete guide: a comprehensive look at the risks and benefits of MDMA. Park Street Press, Rochester, pp 21–28
Carlin AS, Bakker CB, Halpern L, Post RD (1972) Social facilitation of marijuana intoxication: impact of social set and pharmacological activity. J Abnorm Psychol 80:132–140
Chieu CC, Moore KE (1975) D-amphetamine-induced release of “newly synthesized” and “stored” dopamine from the caudate nucleus in vivo. J Pharmacol Exp Ther 192:642–653
de Wit H, Clark M, Brauer LH (1997) Effects of d-amphetamine in grouped versus isolated humans. Pharmacol Biochem Behav 57(1–2):333–340
Derogatis LR, Savitz KL (1999) The SCL-90-R, brief symptom inventory, and matching clinical rating scales. In: The use of psychological testing for treatment planning and outcomes assessment, 2nd edn. Lawrence Erlbaum Associates, Mahwah, pp 679–724
Doty P, de Wit H (1995) Effect of setting on the reinforcing and subjective effects of ethanol in social drinkers. Psychopharmacology (Berl) 118(1):19–27
Evans SM, Griffiths RR, de Wit H (1996) Preference for diazepam, but not buspirone, in moderate drinkers. Psychopharmacology (Berl) 123(2):154–163
Fischman MW, Foltin RW (1991) Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br J Addict 86:1563–1570
Fromme K, Dunn ME (1992) Alcohol expectancies, social and environmental cues as determinants of drinking and perceived reinforcement. Addict Behav 17:167–177
Haney M, Ward AS, Comer SD, Hart CL, Foltin RW, Fischman MW (2001) Bupropion SR worsens mood during marijuana withdrawal in humans. Psychopharmacology (Berl) 155:171–179
Harris DS, Baggott M, Mendelson JH, Mendelson JE, Jones RT (2002) Subjective and hormonal effects of 3, 4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl) 162:396–405
Higgins ST, Stitzer ML (1988) Effects of alcohol on speaking in isolated humans. Psychopharmacology (Berlin) 95:189–194
Hysek CM, Domes G, Liechti ME (2012) MDMA enhances “mind reading” of positive emotions and impairs “mind reading” of negative emotions. Psychopharmacology (Berl) 222(2):293–302
Hysek CM, Schmid Y, Simmler LD, Domes G, Heinrichs M, Eisenegger C, Liechti ME (2013) MDMA enhances emotional empathy and prosocial behavior
Justice AJ, De Wit H (2000) Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol Biochem Behav 66:509–515
Kelly TH, Foltin RW, Mayr MT, Fischman MW (1994) Effects of Δ9-tetrahydrocannabinol and social context on marijuana self-administration by humans. Pharmacol Biochem Behav 49(3):763–768
Kelly BC, Parsons JT, Wells BE (2006) Prevalence and predictors of club drug use among club-going young adults in New York City. J Urban Health 83:884–895
Kirkpatrick MG, de Wit H (2013) In the company of others: social factors alter acute alcohol effects. Psychopharmacology (Berl) 230:215–226
Kirkpatrick MG, Gunderson EW, Perez AY, Haney M, Foltin RW, Hart CL (2012) A direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans. Psychopharmacology (Berl) 219:109–122
Kirkpatrick MG, Baggott MJ, Mendelson JE, Galloway GP, Liechti ME, Hysek CM, de Wit H (2014a) MDMA effects consistent across laboratories. Psychopharmacology: 1–7
Kirkpatrick MG, Lee R, Wardle MC, Jacob S, de Wit H (2014b) Effects of MDMA and intranasal oxytocin on social and emotional processing. Neuropsychopharmacology 39:1654–1663
Lindfors B, Lindman R (1987) Alcohol and previous acquaintance: mood and social interactions in small groups. Scand J Psychol 28(3):211–219
Lokiec F, Jacquot C, Rapin JR, Cohen Y (1977) Effects of amphetamine on brain biogenic amines in isolated and aggregated rats. Eur J Pharmacol 44:391–395
Lokiec F, Jacquot C, Cohen Y (1981) Cageing density and dopamine striatal elimination after amphetamine in the rat. Psychopharmacology (Berl) 73(4):402–403
Marrone GF, Pardo JS, Krauss RM, Hart CL (2010) Amphetamine analogs methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) differentially affect speech. Psychopharmacology (Berlin) 208:169–177
McCroskey JC, McCain TA (1974) The measurement of interpersonal attraction. Speech Monogr 41:261–266
Mohrland JS, Craigmill AL (1978) The effect of aggregation on the lethality of morphine in mice. Arch Int Pharmacodyn Ther 236:252–265
Moore KE, Sawdy LC, Shaul SR (1965) Effects of d-amphetamine on blood glucose and tissue glycogen levels of isolated and aggregated mice. Biochem Pharmacol 14:197–204
Ramos L, Hicks C, Kevin R, Caminer A, Narlawar R, Kassiou M et al (2013) Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor. Neuropsychopharmacology 38(11):2249–2259
Reis HT (2003) A self-report measure of perceived partner responsiveness. University of Rochester
Rodgers J, Buchanan T, Pearson C, Parrott AC, Ling J, Hefferman TM et al (2006) Differential experiences of the psycho-biological sequelae of ecstasy use: quantitative and qualitative data from an internet study. Psychopharmacology (Berl) 20:437–446
Sayette MA, Creswell KG, Dimoff JD, Fairbairn CE, Cohn JF, Heckman BW, Moreland RL (2012) Alcohol and group formation a multimodal investigation of the effects of alcohol on emotion and social bonding. Psychol Sci: 0956797611435134
Schmid Y, Hysek CM, Simmler LD, Crockett MJ, Quednow BB, Liechti ME (2014) Differential effects of MDMA and methylphenidate on social cognition. J Psychopharmacol 28:847–856
Selzer ML, Vinokur A, van Rooijen L (1975) A self-administered short Michigan alcoholism screening test (SMAST). J Stud Alcohol 36:117–126
Sher KJ (1985) Subjective effects of alcohol: the influence of setting and individual differences in alcohol expectancies. J Stud Alcohol 46:137–146
Shintel H, et al. (2006) Accentuate the negative, eliminate the positive? Individual differences in attentional bias to positive and negative information. 47th Annual Meeting of the Psychonomic Society
Smith MA, Pitts EG (2014) Social preference and drug self-administration: a preclinical model of social choice within peer groups. Drug Alcohol Depend 135:140–145
Stitzer ML, Griffiths RR et al (1981) Human social conversation: effects of ethanol, secobarbital and chlorpromazine. Pharmacol Biochem Behav 14(3):353–360
Strickland JC, Smith MA (2014) The effects of social contact on drug use: behavioral mechanisms controlling drug intake. Exp Clin Psychopharmacol 22(1):23–24
Sumnall HR, Cole JC, Jerome L (2006) The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy. Psychopharmacology (Berl) 20:437–446
Tancer M, Johanson CE (2003) Reinforcing, subjective, and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP. Drug Alcohol Depend 72:33–44
Thiel KJ, Okun AC, Neisewander JL (2008) Social reward-conditioned place preference: a model revealing an interaction between cocaine and social context rewards in rats. Drug Alcohol Depend 96(3):202–212
Thiel KJ, Sanabria F, Neisewander JL (2009) Synergistic interaction between nicotine and social rewards in adolescent male rats. Psychopharmacology (Berl) 204(3):391–402
Thompson MR, Hunt GE, McGregor IS (2009) Neural correlates of MDMA (“Ecstasy”)-induced social interaction in rats. Soc Neurosci 4(1):60–72
Ward AS, Kelly TH, Foltin RW, Fischman MW (1997) Effects of d-amphetamine on task performance and social behavior of humans in a residential laboratory. Exp Clin Psychopharmacol 5(2):130
Wardle MC, de Wit H (2014) MDMA alters emotional processing and facilitates positive social interaction. Psychopharmacology (Berl) 231:1–11
Acknowledgments
This research was supported by R21 DA026570 and R01 DA02812 (Harriet de Wit PI). The authors thank Matthew Baggott for the advice, Jonathan Solamillo and Nicole Noga for the excellent technical assistance, and Emmanuel Semmes for the pharmacy support.
Conflict of interest
The authors declare no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Table 1
(DOC 64 kb)
Rights and permissions
About this article
Cite this article
Kirkpatrick, M.G., de Wit, H. MDMA: a social drug in a social context. Psychopharmacology 232, 1155–1163 (2015). https://doi.org/10.1007/s00213-014-3752-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-014-3752-6